• Je něco špatně v tomto záznamu ?

A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer

J. Soukupova, B. Stastna, M. Kanwal, J. Hojny, P. Zemankova, M. Borecka, L. Cerna, M. Cerna, M. Cerna, V. Curtisova, T. Dolezalova, P. Duskova, L. Foretova, O. Havranek, K. Horackova, M. Hovhannisyan, L. Hruskova, S. Chvojka, M. Janatova, M....

. 2024 ; 13 (16) : e70103. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24019432

Grantová podpora
EXCELES - LX22NPO5102 Ministerstvo Školství, Mládeže a Tělovýchovy
LM2023033 Ministerstvo Školství, Mládeže a Tělovýchovy
DRO-VFN-64165 Ministerstvo Zdravotnictví České Republiky
NU-03-00285 Ministerstvo Zdravotnictví České Republiky
NU20-03-00016 Ministerstvo Zdravotnictví České Republiky
NU20-03-00283 Ministerstvo Zdravotnictví České Republiky
SVV 260631 Grantová Agentura, Univerzita Karlova
UNCE/24/MED/022 Grantová Agentura, Univerzita Karlova

BACKGROUND: Monoallelic germline pathogenic variants (GPVs) in five Fanconi anemia (FA) genes (BRCA1/FANCS, BRCA2/FANCD1, PALB2/FANCN, BRIP1/FANCJ, and RAD51C/FANCO) confer an increased risk of breast (BC) and/or ovarian (OC) cancer, but the role of GPVs in 17 other FA genes remains unclear. METHODS: Here, we investigated the association of germline variants in FANCG/XRCC9 with BC and OC risk. RESULTS: The frequency of truncating GPVs in FANCG did not differ between BC (20/10,204; 0.20%) and OC (8/2966; 0.27%) patients compared to controls (6/3250; 0.18%). In addition, only one out of five tumor samples showed loss-of-heterozygosity of the wild-type FANCG allele. Finally, none of the nine functionally tested rare recurrent missense FANCG variants impaired DNA repair activities (FANCD2 monoubiquitination and FANCD2 foci formation) upon DNA damage, in contrast to all tested FANCG truncations. CONCLUSION: Our study suggests that heterozygous germline FANCG variants are unlikely to contribute to the development of BC or OC.

BIOCEV 1st Faculty of Medicine Charles University Vestec Czech Republic

Centre for Medical Genetics and Reproductive Medicine GENNET Prague Czech Republic

Department of Biochemistry Faculty of Science Charles University Prague Czech Republic

Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute Brno Czech Republic

Department of Genetics and Microbiology Faculty of Science Charles University Prague Prague Czech Republic

Department of Medical Genetics AGEL Laboratories AGEL Research and Training Institute Novy Jicin Czech Republic

Department of Medical Genetics Faculty of Medicine and Dentistry University Hospital Olomouc Palacky University Olomouc Czech Republic

Department of Medical Genetics GHC Genetics Prague Czech Republic

Department of Medical Genetics Pronatal Prague Czech Republic

Department of Oncology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Paediatrics and Inherited Metabolic Disorders 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Hospital Ceske Budejovice Ceske Budejovice Czech Republic

Institute for Clinical and Experimental Medicine Prague Czech Republic

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Institute of Medical Biochemistry and Laboratory Diagnostics 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Institute of Medical Genetics University Hospital Pilsen Pilsen Czech Republic

Institute of Pathological Physiology 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Pathology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Laboratory of Cancer Cell Biology Institute of Molecular Genetics of the Czech Academy of Sciences Prague Czech Republic

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019432
003      
CZ-PrNML
005      
20241024110722.0
007      
ta
008      
241015s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/cam4.70103 $2 doi
035    __
$a (PubMed)39149814
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Soukupova, Jana $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
245    12
$a A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer / $c J. Soukupova, B. Stastna, M. Kanwal, J. Hojny, P. Zemankova, M. Borecka, L. Cerna, M. Cerna, M. Cerna, V. Curtisova, T. Dolezalova, P. Duskova, L. Foretova, O. Havranek, K. Horackova, M. Hovhannisyan, L. Hruskova, S. Chvojka, M. Janatova, M. Janikova, S. Jelinkova, P. Just, M. Kalousova, P. Kleiblova, M. Kosarova, M. Koudova, J. Kral, M. Krausova, V. Krutilkova, E. Machackova, K. Matejkova, R. Michalovska, P. Nehasil, B. Nemcova, J. Novotny, M. Palek, P. Pesek, M. Safarikova, O. Scheinost, D. Springer, L. Stolarova, V. Stranecky, I. Subrt, S. Tavandzis, E. Tureckova, K. Vesela, Z. Vlckova, M. Vocka, T. Zima, L. Macurek, Z. Kleibl, CZECANCA consortium
520    9_
$a BACKGROUND: Monoallelic germline pathogenic variants (GPVs) in five Fanconi anemia (FA) genes (BRCA1/FANCS, BRCA2/FANCD1, PALB2/FANCN, BRIP1/FANCJ, and RAD51C/FANCO) confer an increased risk of breast (BC) and/or ovarian (OC) cancer, but the role of GPVs in 17 other FA genes remains unclear. METHODS: Here, we investigated the association of germline variants in FANCG/XRCC9 with BC and OC risk. RESULTS: The frequency of truncating GPVs in FANCG did not differ between BC (20/10,204; 0.20%) and OC (8/2966; 0.27%) patients compared to controls (6/3250; 0.18%). In addition, only one out of five tumor samples showed loss-of-heterozygosity of the wild-type FANCG allele. Finally, none of the nine functionally tested rare recurrent missense FANCG variants impaired DNA repair activities (FANCD2 monoubiquitination and FANCD2 foci formation) upon DNA damage, in contrast to all tested FANCG truncations. CONCLUSION: Our study suggests that heterozygous germline FANCG variants are unlikely to contribute to the development of BC or OC.
650    _2
$a lidé $7 D006801
650    _2
$a ženské pohlaví $7 D005260
650    12
$a zárodečné mutace $7 D018095
650    12
$a genetická predispozice k nemoci $7 D020022
650    12
$a nádory prsu $x genetika $7 D001943
650    12
$a nádory vaječníků $x genetika $7 D010051
650    12
$a protein FANCG $x genetika $7 D052241
650    _2
$a lidé středního věku $7 D008875
650    _2
$a dospělí $7 D000328
650    _2
$a oprava DNA $x genetika $7 D004260
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a senioři $7 D000368
655    _2
$a časopisecké články $7 D016428
700    1_
$a Stastna, Barbora $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Department of Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic
700    1_
$a Kanwal, Madiha $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Hojny, Jan $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Zemankova, Petra $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Borecka, Marianna $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Cerna, Leona $u Centre for Medical Genetics and Reproductive Medicine, GENNET, Prague, Czech Republic
700    1_
$a Cerna, Marta $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Cerna, Monika $u Institute of Medical Genetics, University Hospital Pilsen, Pilsen, Czech Republic
700    1_
$a Curtisova, Vaclava $u Department of Medical Genetics, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University, Olomouc, Czech Republic
700    1_
$a Dolezalova, Tatana $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Duskova, Petra $u Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic
700    1_
$a Foretova, Lenka $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Havranek, Ondrej $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic
700    1_
$a Horackova, Klara $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Hovhannisyan, Milena $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Hruskova, Lucie $u Department of Medical Genetics, GHC Genetics, Prague, Czech Republic
700    1_
$a Chvojka, Stepan $u Centre for Medical Genetics and Reproductive Medicine, GENNET, Prague, Czech Republic
700    1_
$a Janatova, Marketa $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Janikova, Maria $u Department of Medical Genetics, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University, Olomouc, Czech Republic
700    1_
$a Jelinkova, Sandra $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Just, Pavel $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Kalousova, Marta $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Kleiblova, Petra $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Kosarova, Marcela $u Department of Medical Genetics, Pronatal, Prague, Czech Republic
700    1_
$a Koudova, Monika $u Centre for Medical Genetics and Reproductive Medicine, GENNET, Prague, Czech Republic
700    1_
$a Kral, Jan $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Krausova, Michaela $u Institute of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Krutilkova, Vera $u Department of Medical Genetics, AGEL Laboratories, AGEL Research and Training Institute, Novy Jicin, Czech Republic
700    1_
$a Machackova, Eva $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Matejkova, Katerina $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Department of Genetics and Microbiology, Faculty of Science, Charles University in Prague, Prague, Czech Republic
700    1_
$a Michalovska, Renata $u Department of Medical Genetics, GHC Genetics, Prague, Czech Republic
700    1_
$a Nehasil, Petr $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Nemcova, Barbora $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Novotny, Jan $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Palek, Matous $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Pesek, Pavel $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Safarikova, Marketa $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Scheinost, Ondrej $u Hospital Ceske Budejovice, Ceske Budejovice, Czech Republic
700    1_
$a Springer, Drahomira $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Stolarova, Lenka $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Stranecky, Viktor $u Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Subrt, Ivan $u Institute of Medical Genetics, University Hospital Pilsen, Pilsen, Czech Republic
700    1_
$a Tavandzis, Spiros $u Department of Medical Genetics, AGEL Laboratories, AGEL Research and Training Institute, Novy Jicin, Czech Republic
700    1_
$a Tureckova, Eva $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Vesela, Kamila $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Vlckova, Zdenka $u Department of Medical Genetics, GHC Genetics, Prague, Czech Republic
700    1_
$a Vocka, Michal $u Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Zima, Tomas $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
700    1_
$a Macurek, Libor $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000209871238 $7 xx0128728
700    1_
$a Kleibl, Zdenek $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic $u Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000320509667 $7 jo2003183974
710    2_
$a CZECANCA consortium
773    0_
$w MED00181704 $t Cancer medicine $x 2045-7634 $g Roč. 13, č. 16 (2024), s. e70103
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39149814 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110715 $b ABA008
999    __
$a ok $b bmc $g 2201957 $s 1231405
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 13 $c 16 $d e70103 $e - $i 2045-7634 $m Cancer medicine $n Cancer Med $x MED00181704
GRA    __
$a EXCELES - LX22NPO5102 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a LM2023033 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a DRO-VFN-64165 $p Ministerstvo Zdravotnictví České Republiky
GRA    __
$a NU-03-00285 $p Ministerstvo Zdravotnictví České Republiky
GRA    __
$a NU20-03-00016 $p Ministerstvo Zdravotnictví České Republiky
GRA    __
$a NU20-03-00283 $p Ministerstvo Zdravotnictví České Republiky
GRA    __
$a SVV 260631 $p Grantová Agentura, Univerzita Karlova
GRA    __
$a UNCE/24/MED/022 $p Grantová Agentura, Univerzita Karlova
LZP    __
$a Pubmed-20241015

Najít záznam

Citační ukazatele

Možnosti archivace